Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05728944
PHASE3

Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia

Sponsor: LENZ Therapeutics, Inc

View on ClinicalTrials.gov

Summary

Phase 3 Efficacy Study to evaluate the Safety and Efficacy of LNZ100 \& LNZ101 for the Treatment of Presbyopia

Official title: A Multi-Center, Double-Masked Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

Key Details

Gender

All

Age Range

45 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

229

Start Date

2023-03-06

Completion Date

2024-01-24

Last Updated

2026-10-08

Healthy Volunteers

Yes

Interventions

DRUG

Aceclidine+Brimonidine combination ophthalmic solution

Aceclidine + Brimonidine combination ophthalmic solution

DRUG

Aceclidine ophthalmic solution

Aceclidine ophthalmic solution

DRUG

Vehicle

Proprietary vehicle ophthalmic solution

Locations (17)

Site #209

Dothan, Alabama, United States

Site #216

Scottsdale, Arizona, United States

Site #220

Glendale, California, United States

Site #214

La Jolla, California, United States

Site #203

Newport Beach, California, United States

Site #204

Danbury, Connecticut, United States

Site #205

Crystal River, Florida, United States

Site #218

Northbrook, Illinois, United States

Site #211

Louisville, Kentucky, United States

Site #208

St Louis, Missouri, United States

Site #215

Bozeman, Montana, United States

Site #219

Dover, New Jersey, United States

Site #221

Rochester, New York, United States

Site #212

West Fargo, North Dakota, United States

Site #207

Powell, Ohio, United States

Site #213

Eugene, Oregon, United States

Site #217

Warwick, Rhode Island, United States